← Human Trials & Peer-Reviewed Studies

Gender variation in leptin circadian rhythm and pulsatility in adult growth hormone deficiency: effects of growth hormone replacement.

Plain-language guide to PMID 12641632 (2003): clinical trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

Key Facts

PMID
12641632
Journal
Clinical endocrinology
Year
2003
Study type
Clinical Trial
Authors
White HD et al. (6 authors)
DOI
10.1046/j.1365-2265.2003.01742.x

What This Study Did, in Plain Language

What Was Tested

Researchers studied Exogenous HGH, sermorelin & older GHRPs (why they're passed over) in this clinical trial publication.

In both health and AGHD, women exhibit relatively higher leptin concentrations compared to men.

The effect of gender on leptin rhythm and pulse parameters in AGHD is yet to be defined and the gender difference in the response of leptin secretory pattern to GHR has not been determined.

Therefore the aim of this study was to evaluate the effect of gender on circadian and pulse parameters of leptin secretion in AGHD, and examine the gender variation in response of these parameters to GHR.

Who Took Part

PubMed indexes the participants as adults, middle-aged adults and older adults, both men and women.

How the Study Was Run

Plasma leptin was measured at half-hourly intervals for 24 h, before and 1 month after initiation of GHR.

Body composition was measured using bioelectrical impedance.

What Was Measured

PubMed files the paper under topics including Algorithms, Body Composition, Circadian Rhythm, Growth Hormone, Hormone Replacement Therapy, Insulin-Like Growth Factor I and Leptin.

What This Means in Plain Language

This is a clinical trial of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

The abstract goes on to report its results in about 11 sentences; this page does not restate them, so read the paper for the findings and their limits.

The publication is from 2003 (Clinical endocrinology), a journal based in England.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.

Our Notes on the Compound

Exogenous HGH, sermorelin & older GHRPs (why they're passed over): Constant levels suppress the body's own GHRH, raise somatostatin and dull pituitary response.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.